{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-119013","form_type":"8-K","ticker":"HUMA","cik":"0001818382","company_name":"Humacyte, Inc.","filed_at":"2024-11-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.807472+00:00","generated_at":"2026-05-30T00:34:49.726111+00:00","sec_items":["1.01","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Humacyte prices $15M registered direct offering of common stock and warrants at $5.34/unit","bullets":["Pricing of 2,808,988 shares and warrants to purchase up to 2,808,988 shares at $5.34 per unit on Nov 14, 2024.","Gross proceeds of approximately $15M before expenses; closing expected on or about Nov 15, 2024.","Warrants split: 1,404,494 expire in 180 days; 1,404,494 expire in four and one-half years, both at $5.34 exercise.","Company agrees to no further equity issuance or variable rate transactions until FDA approval for extremity vascular trauma or 30 days."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-119013","json":"https://secwatch.observer/filing/0001104659-24-119013.json","markdown":"https://secwatch.observer/filing/0001104659-24-119013.md","text":"https://secwatch.observer/filing/0001104659-24-119013.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1818382/000110465924119013/0001104659-24-119013-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1818382/000110465924119013/tm2428460d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T00:34:49.726111+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}